On the other side, our finding of an association between the expression level of the vesicle protein CD63 and all favorable prognostic features—ER-positive, Luminal-A phenotype, low TIL levels and low CD44 (a marker of stem-cell features)—has not been previously described in breast cancer. Here, CD63 is linked to breast carcinoma.